Class Denied In Paxil Case
Plaintiffs alleging that GlaxoSmithKline PLC knew about risks related to adolescents' use of antidepressant Paxil, but failed to warn doctors and the public, were denied class certification Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article